These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Antineutrophil cytoplasm autoantibodies against bactericidal/permeability-increasing protein in inflammatory bowel disease. Walmsley RS; Zhao MH; Hamilton MI; Brownlee A; Chapman P; Pounder RE; Wakefield AJ; Lockwood CM Gut; 1997 Jan; 40(1):105-9. PubMed ID: 9155585 [TBL] [Abstract][Full Text] [Related]
10. Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical, and surgical treatment. Oudkerk Pool M; Ellerbroek PM; Ridwan BU; Goldschmeding R; von Blomberg BM; Peña AS; Dolman KM; Bril H; Dekker W; Nauta JJ Gut; 1993 Jan; 34(1):46-50. PubMed ID: 8432451 [TBL] [Abstract][Full Text] [Related]
11. Anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease: do they recognize different subsets of a heterogeneous disease? Castellino F; Rosina F; Bansi DS; Bauducci M; Touscoz GA; Giorda L; Borghesio E; Bessone MP; Astegiano M; Musso A Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):859-64. PubMed ID: 8574718 [TBL] [Abstract][Full Text] [Related]
12. Influence of total colectomy on serum antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Patel RT; Stokes R; Birch D; Ibbotson J; Keighley MR Br J Surg; 1994 May; 81(5):724-6. PubMed ID: 8044563 [TBL] [Abstract][Full Text] [Related]
13. ANCA in IBD: nice, but necessary? Heiman DR; DiPalma JA Am J Gastroenterol; 1995 Nov; 90(11):2066-7. PubMed ID: 7485033 [No Abstract] [Full Text] [Related]
16. Anti-neutrophil cytoplasmic antibodies in chronic inflammatory bowel disease. Prevalence and diagnostic role. Hertervig E; Wieslander J; Johansson C; Wiik A; Nilsson A Scand J Gastroenterol; 1995 Jul; 30(7):693-8. PubMed ID: 7481534 [TBL] [Abstract][Full Text] [Related]
17. p-ANCA of undefined specificity in ulcerative colitis: correlation to disease activity and therapy. Rump JA; Wörner I; Roth M; Schölmerich J; Hänsch M; Peter HH Adv Exp Med Biol; 1993; 336():507-13. PubMed ID: 8296665 [TBL] [Abstract][Full Text] [Related]
18. Antibodies to the cytoskeleton components and other autoantibodies in inflammatory bowel disease. Zauli D; Crespi C; Dall'Amore P; Bianchi FB; Pisi E Digestion; 1985; 32(2):140-4. PubMed ID: 2412921 [TBL] [Abstract][Full Text] [Related]
19. A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease. Rump JA; Schölmerich J; Gross V; Roth M; Helfesrieder R; Rautmann A; Lüdemann J; Gross WL; Peter HH Immunobiology; 1990 Nov; 181(4-5):406-13. PubMed ID: 2099908 [TBL] [Abstract][Full Text] [Related]
20. Inflammatory bowel disease-specific autoantibodies in HLA-B27-associated spondyloarthropathies: increased prevalence of ASCA and pANCA. Török HP; Glas J; Gruber R; Brumberger V; Strasser C; Kellner H; Märker-Hermann E; Folwaczny C Digestion; 2004; 70(1):49-54. PubMed ID: 15308872 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]